Clinical Trial Update: Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial sponsored by the Children's Oncology Group is evaluating whether xylitol dental wipes can reduce bloodstream infection risk in children…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Xylitol dental wipes (xylitol dental wipe formulation)

Snippet

Sponsor: Children's Oncology Group | Conditions: Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia | Phase 3 | Status: NOT_YET_RECRUITING